Celiac Disease
Authors:
- 1 March 2013
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 56 (3) , 251-256
Abstract
Background: The need for an early and accurate diagnosis in celiac disease (CD) has focused attention on new diagnostic approaches, based on the efficiency of serological markers and the high negative predictive value of human leukocyte antigen (HLA) non‐DQ2/8.Methods: We performed a retrospective review of all of the patients suspected of having CD who had undergone a small bowel biopsy in our gastroenterology unit. All symptomatic children with serological marker at time of biopsy (immunoglobulin A‐tissue transglutaminase antibody, endomysial antibody, and HLA genotype) were included. The triple test (TT) was positive if immunoglobulin A‐tissue transglutaminase antibody was 10 times the upper limit of normal, plus positive endomysial antibody plus human leukocyte antigen‐DQ2/DQ8.Results: A total of 150 patients met the inclusion criteria and were enrolled in the study. One hundred sixteen were positive for the TT; 113 of 116 (97.4%) had a Marsh 2/3 histological lesion and had been considered to have CD. Thus, positive predictive value of the TT was 97.4%. The other 3 cases (2.6%) had Marsh 0/1 lesion, so we consider them to be false‐positives for the TT; however, on follow‐up, all 3 children developed histological damage after a gluten challenge. Finally, the positive predictive value of the TT was 100%. Thirty‐four patients were negative for the TT: 22 patients are celiac, 3 are celiac but challenge gluten diet is pending, and the 9 patients left have other gastrointestinal disorder.Conclusions: Our study supports the view that in selected children who are symptomatic and positive for the TT, CD diagnosis could be established independent of histological findings.Keywords
This publication has 51 references indexed in Scilit:
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2012
- Celiac Disease without Villous Atrophy in Children: A Prospective StudyThe Journal of Pediatrics, 2010
- Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue TransglutaminaseJournal of Pediatric Gastroenterology and Nutrition, 2010
- Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseasesClinical and Experimental Immunology, 2009
- A Report on the International Transglutaminase Autoantibody Workshop for Celiac DiseaseAmerican Journal of Gastroenterology, 2008
- Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of AgeJournal of Pediatric Gastroenterology and Nutrition, 2008
- Gluten‐dependent Small Bowel Mucosal Transglutaminase 2–specific IgA Deposits in Overt and Mild Enteropathy Coeliac DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2008
- What Is the Role of Serologic Testing in Celiac Disease? A Prospective, Biopsy-Confirmed Study With Economic AnalysisClinical Gastroenterology and Hepatology, 2008
- Coeliac disease: a biopsy is not always necessary for diagnosisAlimentary Pharmacology & Therapeutics, 2008
- Latent coeliac disease or coeliac disease beyond villous atrophy?Gut, 2007